nodes	percent_of_prediction	percent_of_DWPC	metapath
Pyridostigmine—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.156	0.282	CbGbCtD
Pyridostigmine—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.105	0.19	CbGbCtD
Pyridostigmine—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.101	0.182	CbGbCtD
Pyridostigmine—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.0896	0.162	CbGbCtD
Pyridostigmine—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.0526	0.0949	CbGbCtD
Pyridostigmine—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.0497	0.0897	CbGbCtD
Pyridostigmine—BCHE—diaphragm—chronic obstructive pulmonary disease	0.0125	0.692	CbGeAlD
Pyridostigmine—Sputum increased—Arformoterol—chronic obstructive pulmonary disease	0.0124	0.0322	CcSEcCtD
Pyridostigmine—Acute bronchitis—Formoterol—chronic obstructive pulmonary disease	0.0124	0.0322	CcSEcCtD
Pyridostigmine—Sputum increased—Formoterol—chronic obstructive pulmonary disease	0.0124	0.0322	CcSEcCtD
Pyridostigmine—Acute bronchitis—Arformoterol—chronic obstructive pulmonary disease	0.0124	0.0322	CcSEcCtD
Pyridostigmine—Hallucination, visual—Montelukast—chronic obstructive pulmonary disease	0.0121	0.0315	CcSEcCtD
Pyridostigmine—Acute bronchitis—Montelukast—chronic obstructive pulmonary disease	0.0121	0.0315	CcSEcCtD
Pyridostigmine—Increased bronchial secretion—Formoterol—chronic obstructive pulmonary disease	0.0116	0.0302	CcSEcCtD
Pyridostigmine—Increased bronchial secretion—Arformoterol—chronic obstructive pulmonary disease	0.0116	0.0302	CcSEcCtD
Pyridostigmine—Tracheobronchitis—Formoterol—chronic obstructive pulmonary disease	0.0107	0.0278	CcSEcCtD
Pyridostigmine—Tracheobronchitis—Arformoterol—chronic obstructive pulmonary disease	0.0107	0.0278	CcSEcCtD
Pyridostigmine—Tracheobronchitis—Montelukast—chronic obstructive pulmonary disease	0.0105	0.0272	CcSEcCtD
Pyridostigmine—Abdominal bloating—Salbutamol—chronic obstructive pulmonary disease	0.0064	0.0166	CcSEcCtD
Pyridostigmine—Abdominal cramps—Aminophylline—chronic obstructive pulmonary disease	0.00628	0.0163	CcSEcCtD
Pyridostigmine—Pallor—Salbutamol—chronic obstructive pulmonary disease	0.00367	0.00956	CcSEcCtD
Pyridostigmine—Musculoskeletal stiffness—Arformoterol—chronic obstructive pulmonary disease	0.00359	0.00936	CcSEcCtD
Pyridostigmine—Musculoskeletal stiffness—Formoterol—chronic obstructive pulmonary disease	0.00359	0.00936	CcSEcCtD
Pyridostigmine—Chest discomfort—Salbutamol—chronic obstructive pulmonary disease	0.00344	0.00896	CcSEcCtD
Pyridostigmine—CYP3A4—Lidocaine metabolism—CYP1A2—chronic obstructive pulmonary disease	0.0034	0.0776	CbGpPWpGaD
Pyridostigmine—Dysmenorrhoea—Salbutamol—chronic obstructive pulmonary disease	0.00335	0.00872	CcSEcCtD
Pyridostigmine—Blood pressure increased—Formoterol—chronic obstructive pulmonary disease	0.00322	0.00839	CcSEcCtD
Pyridostigmine—Blood pressure increased—Arformoterol—chronic obstructive pulmonary disease	0.00322	0.00839	CcSEcCtD
Pyridostigmine—Blood pressure increased—Salbutamol—chronic obstructive pulmonary disease	0.00305	0.00793	CcSEcCtD
Pyridostigmine—CYP3A4—Aflatoxin B1 metabolism—EPHX1—chronic obstructive pulmonary disease	0.003	0.0686	CbGpPWpGaD
Pyridostigmine—Pulmonary oedema—Salbutamol—chronic obstructive pulmonary disease	0.00271	0.00705	CcSEcCtD
Pyridostigmine—Muscle spasms—Roflumilast—chronic obstructive pulmonary disease	0.00267	0.00695	CcSEcCtD
Pyridostigmine—Hypertonia—Salbutamol—chronic obstructive pulmonary disease	0.00267	0.00695	CcSEcCtD
Pyridostigmine—Dry skin—Tiotropium—chronic obstructive pulmonary disease	0.00266	0.00692	CcSEcCtD
Pyridostigmine—Vertigo—Roflumilast—chronic obstructive pulmonary disease	0.0025	0.0065	CcSEcCtD
Pyridostigmine—CYP3A4—Benzo(a)pyrene metabolism—EPHX1—chronic obstructive pulmonary disease	0.00246	0.0561	CbGpPWpGaD
Pyridostigmine—Myalgia—Roflumilast—chronic obstructive pulmonary disease	0.00236	0.00616	CcSEcCtD
Pyridostigmine—Dry skin—Arformoterol—chronic obstructive pulmonary disease	0.00215	0.00559	CcSEcCtD
Pyridostigmine—Dry skin—Formoterol—chronic obstructive pulmonary disease	0.00215	0.00559	CcSEcCtD
Pyridostigmine—Epistaxis—Tiotropium—chronic obstructive pulmonary disease	0.00211	0.00549	CcSEcCtD
Pyridostigmine—Cramp muscle—Formoterol—chronic obstructive pulmonary disease	0.00211	0.00549	CcSEcCtD
Pyridostigmine—Cramp muscle—Arformoterol—chronic obstructive pulmonary disease	0.00211	0.00549	CcSEcCtD
Pyridostigmine—Musculoskeletal discomfort—Roflumilast—chronic obstructive pulmonary disease	0.00207	0.00538	CcSEcCtD
Pyridostigmine—Cramp muscle—Montelukast—chronic obstructive pulmonary disease	0.00206	0.00537	CcSEcCtD
Pyridostigmine—Asthma—Formoterol—chronic obstructive pulmonary disease	0.00202	0.00527	CcSEcCtD
Pyridostigmine—Asthma—Arformoterol—chronic obstructive pulmonary disease	0.00202	0.00527	CcSEcCtD
Pyridostigmine—Cramp muscle—Salbutamol—chronic obstructive pulmonary disease	0.00199	0.00518	CcSEcCtD
Pyridostigmine—Asthma—Montelukast—chronic obstructive pulmonary disease	0.00198	0.00516	CcSEcCtD
Pyridostigmine—Bronchitis—Arformoterol—chronic obstructive pulmonary disease	0.00195	0.00506	CcSEcCtD
Pyridostigmine—Bronchitis—Formoterol—chronic obstructive pulmonary disease	0.00195	0.00506	CcSEcCtD
Pyridostigmine—Abdominal distension—Salbutamol—chronic obstructive pulmonary disease	0.00192	0.00501	CcSEcCtD
Pyridostigmine—Asthma—Salbutamol—chronic obstructive pulmonary disease	0.00191	0.00497	CcSEcCtD
Pyridostigmine—Bronchitis—Montelukast—chronic obstructive pulmonary disease	0.00191	0.00496	CcSEcCtD
Pyridostigmine—Alopecia—Aminophylline—chronic obstructive pulmonary disease	0.00188	0.00489	CcSEcCtD
Pyridostigmine—Feeling abnormal—Roflumilast—chronic obstructive pulmonary disease	0.00187	0.00486	CcSEcCtD
Pyridostigmine—Sweating increased—Salbutamol—chronic obstructive pulmonary disease	0.00186	0.00484	CcSEcCtD
Pyridostigmine—Gastrointestinal pain—Roflumilast—chronic obstructive pulmonary disease	0.00185	0.00483	CcSEcCtD
Pyridostigmine—Bronchitis—Salbutamol—chronic obstructive pulmonary disease	0.00184	0.00478	CcSEcCtD
Pyridostigmine—Urticaria—Roflumilast—chronic obstructive pulmonary disease	0.0018	0.00469	CcSEcCtD
Pyridostigmine—Delusion—Prednisone—chronic obstructive pulmonary disease	0.00179	0.00467	CcSEcCtD
Pyridostigmine—Abdominal pain—Roflumilast—chronic obstructive pulmonary disease	0.00179	0.00466	CcSEcCtD
Pyridostigmine—Drowsiness—Montelukast—chronic obstructive pulmonary disease	0.00177	0.0046	CcSEcCtD
Pyridostigmine—Drowsiness—Salbutamol—chronic obstructive pulmonary disease	0.0017	0.00443	CcSEcCtD
Pyridostigmine—Agitation—Aminophylline—chronic obstructive pulmonary disease	0.0017	0.00443	CcSEcCtD
Pyridostigmine—Hypersensitivity—Roflumilast—chronic obstructive pulmonary disease	0.00167	0.00435	CcSEcCtD
Pyridostigmine—Epistaxis—Montelukast—chronic obstructive pulmonary disease	0.00167	0.00434	CcSEcCtD
Pyridostigmine—Asthenia—Roflumilast—chronic obstructive pulmonary disease	0.00163	0.00423	CcSEcCtD
Pyridostigmine—Epistaxis—Salbutamol—chronic obstructive pulmonary disease	0.00161	0.00418	CcSEcCtD
Pyridostigmine—Convulsion—Aminophylline—chronic obstructive pulmonary disease	0.0016	0.00418	CcSEcCtD
Pyridostigmine—Hypoaesthesia—Montelukast—chronic obstructive pulmonary disease	0.00158	0.00411	CcSEcCtD
Pyridostigmine—Pulmonary oedema—Prednisolone—chronic obstructive pulmonary disease	0.00155	0.00405	CcSEcCtD
Pyridostigmine—Diarrhoea—Roflumilast—chronic obstructive pulmonary disease	0.00155	0.00404	CcSEcCtD
Pyridostigmine—Loss of consciousness—Tiotropium—chronic obstructive pulmonary disease	0.00154	0.004	CcSEcCtD
Pyridostigmine—ACHE—Monoamine Transport—SLC6A4—chronic obstructive pulmonary disease	0.00152	0.0348	CbGpPWpGaD
Pyridostigmine—Hypoaesthesia—Salbutamol—chronic obstructive pulmonary disease	0.00152	0.00396	CcSEcCtD
Pyridostigmine—ACHE—Melatonin metabolism and effects—CYP1A2—chronic obstructive pulmonary disease	0.00149	0.0341	CbGpPWpGaD
Pyridostigmine—Myalgia—Tiotropium—chronic obstructive pulmonary disease	0.00149	0.00387	CcSEcCtD
Pyridostigmine—Thrombophlebitis—Prednisolone—chronic obstructive pulmonary disease	0.00146	0.00381	CcSEcCtD
Pyridostigmine—ACHE—Synthesis, secretion, and deacylation of Ghrelin—LEP—chronic obstructive pulmonary disease	0.00144	0.0329	CbGpPWpGaD
Pyridostigmine—Vomiting—Roflumilast—chronic obstructive pulmonary disease	0.00144	0.00375	CcSEcCtD
Pyridostigmine—Rash—Roflumilast—chronic obstructive pulmonary disease	0.00143	0.00372	CcSEcCtD
Pyridostigmine—Dermatitis—Roflumilast—chronic obstructive pulmonary disease	0.00143	0.00372	CcSEcCtD
Pyridostigmine—BCHE—respiratory system—chronic obstructive pulmonary disease	0.00142	0.079	CbGeAlD
Pyridostigmine—Headache—Roflumilast—chronic obstructive pulmonary disease	0.00142	0.0037	CcSEcCtD
Pyridostigmine—Hypotension—Aminophylline—chronic obstructive pulmonary disease	0.00141	0.00368	CcSEcCtD
Pyridostigmine—Muscle spasms—Arformoterol—chronic obstructive pulmonary disease	0.00136	0.00353	CcSEcCtD
Pyridostigmine—Muscle spasms—Formoterol—chronic obstructive pulmonary disease	0.00136	0.00353	CcSEcCtD
Pyridostigmine—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.00135	0.0035	CcSEcCtD
Pyridostigmine—Muscle spasms—Montelukast—chronic obstructive pulmonary disease	0.00133	0.00346	CcSEcCtD
Pyridostigmine—Flatulence—Salbutamol—chronic obstructive pulmonary disease	0.00131	0.00341	CcSEcCtD
Pyridostigmine—Musculoskeletal discomfort—Tiotropium—chronic obstructive pulmonary disease	0.0013	0.00338	CcSEcCtD
Pyridostigmine—Agitation—Arformoterol—chronic obstructive pulmonary disease	0.0013	0.00337	CcSEcCtD
Pyridostigmine—Agitation—Formoterol—chronic obstructive pulmonary disease	0.0013	0.00337	CcSEcCtD
Pyridostigmine—BCHE—Synthesis, secretion, and deacylation of Ghrelin—LEP—chronic obstructive pulmonary disease	0.00129	0.0294	CbGpPWpGaD
Pyridostigmine—Paraesthesia—Tiotropium—chronic obstructive pulmonary disease	0.00128	0.00333	CcSEcCtD
Pyridostigmine—Muscle spasms—Salbutamol—chronic obstructive pulmonary disease	0.00128	0.00333	CcSEcCtD
Pyridostigmine—Agitation—Montelukast—chronic obstructive pulmonary disease	0.00127	0.0033	CcSEcCtD
Pyridostigmine—CYP3A4—Aflatoxin B1 metabolism—CYP1A2—chronic obstructive pulmonary disease	0.00125	0.0285	CbGpPWpGaD
Pyridostigmine—Gastrointestinal pain—Aminophylline—chronic obstructive pulmonary disease	0.00124	0.00322	CcSEcCtD
Pyridostigmine—Agitation—Salbutamol—chronic obstructive pulmonary disease	0.00122	0.00318	CcSEcCtD
Pyridostigmine—Cardiac arrest—Prednisolone—chronic obstructive pulmonary disease	0.00121	0.00314	CcSEcCtD
Pyridostigmine—Urticaria—Aminophylline—chronic obstructive pulmonary disease	0.0012	0.00313	CcSEcCtD
Pyridostigmine—Myalgia—Arformoterol—chronic obstructive pulmonary disease	0.0012	0.00312	CcSEcCtD
Pyridostigmine—Myalgia—Formoterol—chronic obstructive pulmonary disease	0.0012	0.00312	CcSEcCtD
Pyridostigmine—Convulsion—Montelukast—chronic obstructive pulmonary disease	0.0012	0.00311	CcSEcCtD
Pyridostigmine—Vertigo—Salbutamol—chronic obstructive pulmonary disease	0.0012	0.00311	CcSEcCtD
Pyridostigmine—Abdominal pain—Aminophylline—chronic obstructive pulmonary disease	0.0012	0.00311	CcSEcCtD
Pyridostigmine—Myalgia—Montelukast—chronic obstructive pulmonary disease	0.00118	0.00306	CcSEcCtD
Pyridostigmine—BCHE—bronchus—chronic obstructive pulmonary disease	0.00117	0.065	CbGeAlD
Pyridostigmine—Loss of consciousness—Salbutamol—chronic obstructive pulmonary disease	0.00117	0.00305	CcSEcCtD
Pyridostigmine—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	0.00117	0.00303	CcSEcCtD
Pyridostigmine—Dry skin—Prednisolone—chronic obstructive pulmonary disease	0.00116	0.00302	CcSEcCtD
Pyridostigmine—ACHE—Melatonin metabolism and effects—EDN1—chronic obstructive pulmonary disease	0.00116	0.0264	CbGpPWpGaD
Pyridostigmine—BCHE—smooth muscle tissue—chronic obstructive pulmonary disease	0.00115	0.0636	CbGeAlD
Pyridostigmine—Myalgia—Salbutamol—chronic obstructive pulmonary disease	0.00113	0.00295	CcSEcCtD
Pyridostigmine—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.00113	0.00295	CcSEcCtD
Pyridostigmine—Pulmonary oedema—Prednisone—chronic obstructive pulmonary disease	0.00113	0.00294	CcSEcCtD
Pyridostigmine—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.00113	0.00293	CcSEcCtD
Pyridostigmine—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.00111	0.0029	CcSEcCtD
Pyridostigmine—Abdominal distension—Prednisolone—chronic obstructive pulmonary disease	0.0011	0.00287	CcSEcCtD
Pyridostigmine—ACHE—Melatonin metabolism and effects—CYP1A1—chronic obstructive pulmonary disease	0.00108	0.0248	CbGpPWpGaD
Pyridostigmine—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.00108	0.0028	CcSEcCtD
Pyridostigmine—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.00108	0.0028	CcSEcCtD
Pyridostigmine—Sweating increased—Prednisolone—chronic obstructive pulmonary disease	0.00107	0.00278	CcSEcCtD
Pyridostigmine—Thrombophlebitis—Prednisone—chronic obstructive pulmonary disease	0.00106	0.00277	CcSEcCtD
Pyridostigmine—BCHE—trachea—chronic obstructive pulmonary disease	0.00105	0.0584	CbGeAlD
Pyridostigmine—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.00105	0.00273	CcSEcCtD
Pyridostigmine—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	0.00105	0.00273	CcSEcCtD
Pyridostigmine—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.00105	0.00273	CcSEcCtD
Pyridostigmine—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.00105	0.00273	CcSEcCtD
Pyridostigmine—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.00103	0.00269	CcSEcCtD
Pyridostigmine—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.00103	0.00267	CcSEcCtD
Pyridostigmine—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.00102	0.00266	CcSEcCtD
Pyridostigmine—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.00102	0.00266	CcSEcCtD
Pyridostigmine—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.00102	0.00264	CcSEcCtD
Pyridostigmine—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.00101	0.00263	CcSEcCtD
Pyridostigmine—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.001	0.00261	CcSEcCtD
Pyridostigmine—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.00099	0.00258	CcSEcCtD
Pyridostigmine—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.000975	0.00254	CcSEcCtD
Pyridostigmine—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.000966	0.00251	CcSEcCtD
Pyridostigmine—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000961	0.0025	CcSEcCtD
Pyridostigmine—CYP3A4—Aflatoxin B1 metabolism—GSTM1—chronic obstructive pulmonary disease	0.000956	0.0218	CbGpPWpGaD
Pyridostigmine—ACHE—ATF-2 transcription factor network—TGFB2—chronic obstructive pulmonary disease	0.000953	0.0218	CbGpPWpGaD
Pyridostigmine—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000953	0.00248	CcSEcCtD
Pyridostigmine—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000952	0.00248	CcSEcCtD
Pyridostigmine—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.000948	0.00247	CcSEcCtD
Pyridostigmine—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.000948	0.00247	CcSEcCtD
Pyridostigmine—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000947	0.00247	CcSEcCtD
Pyridostigmine—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.000941	0.00245	CcSEcCtD
Pyridostigmine—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.000941	0.00245	CcSEcCtD
Pyridostigmine—Lethargy—Prednisone—chronic obstructive pulmonary disease	0.00094	0.00245	CcSEcCtD
Pyridostigmine—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.000921	0.0024	CcSEcCtD
Pyridostigmine—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.000914	0.00238	CcSEcCtD
Pyridostigmine—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.000914	0.00238	CcSEcCtD
Pyridostigmine—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.000909	0.00237	CcSEcCtD
Pyridostigmine—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.000909	0.00237	CcSEcCtD
Pyridostigmine—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000906	0.00236	CcSEcCtD
Pyridostigmine—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000899	0.00234	CcSEcCtD
Pyridostigmine—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000898	0.00234	CcSEcCtD
Pyridostigmine—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000898	0.00234	CcSEcCtD
Pyridostigmine—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.000895	0.00233	CcSEcCtD
Pyridostigmine—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.000895	0.00233	CcSEcCtD
Pyridostigmine—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000893	0.00232	CcSEcCtD
Pyridostigmine—Bradycardia—Prednisolone—chronic obstructive pulmonary disease	0.000893	0.00232	CcSEcCtD
Pyridostigmine—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.000891	0.00232	CcSEcCtD
Pyridostigmine—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.000888	0.00231	CcSEcCtD
Pyridostigmine—Cardiac arrest—Prednisone—chronic obstructive pulmonary disease	0.000876	0.00228	CcSEcCtD
Pyridostigmine—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.000863	0.00225	CcSEcCtD
Pyridostigmine—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.000859	0.00224	CcSEcCtD
Pyridostigmine—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.000848	0.00221	CcSEcCtD
Pyridostigmine—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.000848	0.00221	CcSEcCtD
Pyridostigmine—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000847	0.0022	CcSEcCtD
Pyridostigmine—Dry skin—Prednisone—chronic obstructive pulmonary disease	0.000844	0.0022	CcSEcCtD
Pyridostigmine—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.00083	0.00216	CcSEcCtD
Pyridostigmine—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000825	0.00215	CcSEcCtD
Pyridostigmine—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000825	0.00215	CcSEcCtD
Pyridostigmine—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000809	0.0021	CcSEcCtD
Pyridostigmine—Abdominal distension—Prednisone—chronic obstructive pulmonary disease	0.000802	0.00209	CcSEcCtD
Pyridostigmine—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.0008	0.00208	CcSEcCtD
Pyridostigmine—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000787	0.00205	CcSEcCtD
Pyridostigmine—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000787	0.00205	CcSEcCtD
Pyridostigmine—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000779	0.00203	CcSEcCtD
Pyridostigmine—Sweating increased—Prednisone—chronic obstructive pulmonary disease	0.000776	0.00202	CcSEcCtD
Pyridostigmine—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000771	0.00201	CcSEcCtD
Pyridostigmine—BCHE—lung—chronic obstructive pulmonary disease	0.000755	0.0419	CbGeAlD
Pyridostigmine—ACHE—Integrated Pancreatic Cancer Pathway—RAPGEF3—chronic obstructive pulmonary disease	0.000748	0.0171	CbGpPWpGaD
Pyridostigmine—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000743	0.00193	CcSEcCtD
Pyridostigmine—CYP3A4—Benzo(a)pyrene metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000741	0.0169	CbGpPWpGaD
Pyridostigmine—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000732	0.0019	CcSEcCtD
Pyridostigmine—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000732	0.0019	CcSEcCtD
Pyridostigmine—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000725	0.00189	CcSEcCtD
Pyridostigmine—Rash—Formoterol—chronic obstructive pulmonary disease	0.000725	0.00189	CcSEcCtD
Pyridostigmine—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000725	0.00189	CcSEcCtD
Pyridostigmine—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000725	0.00189	CcSEcCtD
Pyridostigmine—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000721	0.00188	CcSEcCtD
Pyridostigmine—Headache—Formoterol—chronic obstructive pulmonary disease	0.000721	0.00188	CcSEcCtD
Pyridostigmine—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000716	0.00187	CcSEcCtD
Pyridostigmine—Rash—Montelukast—chronic obstructive pulmonary disease	0.000711	0.00185	CcSEcCtD
Pyridostigmine—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.00071	0.00185	CcSEcCtD
Pyridostigmine—Headache—Montelukast—chronic obstructive pulmonary disease	0.000706	0.00184	CcSEcCtD
Pyridostigmine—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000691	0.0018	CcSEcCtD
Pyridostigmine—Vertigo—Prednisolone—chronic obstructive pulmonary disease	0.000686	0.00179	CcSEcCtD
Pyridostigmine—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000685	0.00178	CcSEcCtD
Pyridostigmine—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000684	0.00178	CcSEcCtD
Pyridostigmine—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000683	0.00178	CcSEcCtD
Pyridostigmine—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000683	0.00178	CcSEcCtD
Pyridostigmine—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000681	0.00177	CcSEcCtD
Pyridostigmine—Loss of consciousness—Prednisolone—chronic obstructive pulmonary disease	0.000671	0.00175	CcSEcCtD
Pyridostigmine—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000669	0.00174	CcSEcCtD
Pyridostigmine—Convulsion—Prednisolone—chronic obstructive pulmonary disease	0.000661	0.00172	CcSEcCtD
Pyridostigmine—Bradycardia—Prednisone—chronic obstructive pulmonary disease	0.000649	0.00169	CcSEcCtD
Pyridostigmine—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000645	0.00168	CcSEcCtD
Pyridostigmine—CYP3A4—Fatty Acid Omega Oxidation—CYP1A2—chronic obstructive pulmonary disease	0.000644	0.0147	CbGpPWpGaD
Pyridostigmine—ACHE—Peptide hormone metabolism—ACE—chronic obstructive pulmonary disease	0.000641	0.0146	CbGpPWpGaD
Pyridostigmine—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	0.000602	0.00157	CcSEcCtD
Pyridostigmine—CYP3A4—Estrogen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000586	0.0134	CbGpPWpGaD
Pyridostigmine—ACHE—Transmission across Chemical Synapses—CHRNA5—chronic obstructive pulmonary disease	0.000581	0.0133	CbGpPWpGaD
Pyridostigmine—BCHE—Peptide hormone metabolism—ACE—chronic obstructive pulmonary disease	0.000572	0.0131	CbGpPWpGaD
Pyridostigmine—Alopecia—Prednisone—chronic obstructive pulmonary disease	0.000563	0.00147	CcSEcCtD
Pyridostigmine—CYP3A4—Aflatoxin activation and detoxification—CYP1A2—chronic obstructive pulmonary disease	0.000561	0.0128	CbGpPWpGaD
Pyridostigmine—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	0.000559	0.00146	CcSEcCtD
Pyridostigmine—ACHE—Monoamine Transport—IL1B—chronic obstructive pulmonary disease	0.000554	0.0127	CbGpPWpGaD
Pyridostigmine—ACHE—ATF-2 transcription factor network—PLAU—chronic obstructive pulmonary disease	0.000541	0.0123	CbGpPWpGaD
Pyridostigmine—CYP3A4—Xenobiotics—CYP1A2—chronic obstructive pulmonary disease	0.000539	0.0123	CbGpPWpGaD
Pyridostigmine—BCHE—Transmission across Chemical Synapses—CHRNA5—chronic obstructive pulmonary disease	0.000518	0.0118	CbGpPWpGaD
Pyridostigmine—CYP3A4—Tamoxifen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000518	0.0118	CbGpPWpGaD
Pyridostigmine—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	0.000513	0.00134	CcSEcCtD
Pyridostigmine—Agitation—Prednisone—chronic obstructive pulmonary disease	0.00051	0.00133	CcSEcCtD
Pyridostigmine—Vertigo—Prednisone—chronic obstructive pulmonary disease	0.000498	0.0013	CcSEcCtD
Pyridostigmine—ACHE—ATF-2 transcription factor network—NOS2—chronic obstructive pulmonary disease	0.000497	0.0113	CbGpPWpGaD
Pyridostigmine—Urticaria—Prednisolone—chronic obstructive pulmonary disease	0.000495	0.00129	CcSEcCtD
Pyridostigmine—Loss of consciousness—Prednisone—chronic obstructive pulmonary disease	0.000488	0.00127	CcSEcCtD
Pyridostigmine—Convulsion—Prednisone—chronic obstructive pulmonary disease	0.000481	0.00125	CcSEcCtD
Pyridostigmine—ACHE—Transmission across Chemical Synapses—CHRNA3—chronic obstructive pulmonary disease	0.000474	0.0108	CbGpPWpGaD
Pyridostigmine—Myalgia—Prednisone—chronic obstructive pulmonary disease	0.000472	0.00123	CcSEcCtD
Pyridostigmine—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—chronic obstructive pulmonary disease	0.000468	0.0107	CbGpPWpGaD
Pyridostigmine—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.000459	0.00119	CcSEcCtD
Pyridostigmine—CYP3A4—Estrogen metabolism—GSTM1—chronic obstructive pulmonary disease	0.000449	0.0103	CbGpPWpGaD
Pyridostigmine—ACHE—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.000445	0.0102	CbGpPWpGaD
Pyridostigmine—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	0.000438	0.00114	CcSEcCtD
Pyridostigmine—CYP3A4—Estrogen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000426	0.00972	CbGpPWpGaD
Pyridostigmine—BCHE—Transmission across Chemical Synapses—CHRNA3—chronic obstructive pulmonary disease	0.000423	0.00965	CbGpPWpGaD
Pyridostigmine—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	0.000413	0.00107	CcSEcCtD
Pyridostigmine—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	0.000407	0.00106	CcSEcCtD
Pyridostigmine—ACHE—Monoamine Transport—TNF—chronic obstructive pulmonary disease	0.000402	0.00919	CbGpPWpGaD
Pyridostigmine—ACHE—Peptide hormone metabolism—LEP—chronic obstructive pulmonary disease	0.000398	0.00909	CbGpPWpGaD
Pyridostigmine—BCHE—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.000397	0.00907	CbGpPWpGaD
Pyridostigmine—Rash—Prednisolone—chronic obstructive pulmonary disease	0.000393	0.00102	CcSEcCtD
Pyridostigmine—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.000392	0.00102	CcSEcCtD
Pyridostigmine—CYP3A4—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	0.000391	0.00894	CbGpPWpGaD
Pyridostigmine—Headache—Prednisolone—chronic obstructive pulmonary disease	0.00039	0.00102	CcSEcCtD
Pyridostigmine—CYP3A4—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000376	0.00859	CbGpPWpGaD
Pyridostigmine—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	0.000373	0.000971	CcSEcCtD
Pyridostigmine—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	0.00037	0.000964	CcSEcCtD
Pyridostigmine—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.00037	0.000963	CcSEcCtD
Pyridostigmine—ACHE—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.000363	0.00829	CbGpPWpGaD
Pyridostigmine—Urticaria—Prednisone—chronic obstructive pulmonary disease	0.00036	0.000936	CcSEcCtD
Pyridostigmine—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	0.000358	0.000932	CcSEcCtD
Pyridostigmine—BCHE—Peptide hormone metabolism—LEP—chronic obstructive pulmonary disease	0.000355	0.00811	CbGpPWpGaD
Pyridostigmine—ACHE—ATF-2 transcription factor network—CXCL8—chronic obstructive pulmonary disease	0.000354	0.00809	CbGpPWpGaD
Pyridostigmine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—chronic obstructive pulmonary disease	0.000352	0.00805	CbGpPWpGaD
Pyridostigmine—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	0.000334	0.000868	CcSEcCtD
Pyridostigmine—Asthenia—Prednisone—chronic obstructive pulmonary disease	0.000325	0.000846	CcSEcCtD
Pyridostigmine—BCHE—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.000324	0.00739	CbGpPWpGaD
Pyridostigmine—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	0.00031	0.000806	CcSEcCtD
Pyridostigmine—ACHE—Metabolism of proteins—MUC5AC—chronic obstructive pulmonary disease	0.000309	0.00705	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	0.000304	0.00694	CbGpPWpGaD
Pyridostigmine—Vomiting—Prednisone—chronic obstructive pulmonary disease	0.000288	0.000749	CcSEcCtD
Pyridostigmine—Rash—Prednisone—chronic obstructive pulmonary disease	0.000285	0.000743	CcSEcCtD
Pyridostigmine—Dermatitis—Prednisone—chronic obstructive pulmonary disease	0.000285	0.000742	CcSEcCtD
Pyridostigmine—Headache—Prednisone—chronic obstructive pulmonary disease	0.000284	0.000738	CcSEcCtD
Pyridostigmine—CYP3A4—Tryptophan metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000277	0.00632	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism of proteins—MUC5AC—chronic obstructive pulmonary disease	0.000275	0.00629	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	0.000271	0.00619	CbGpPWpGaD
Pyridostigmine—Nausea—Prednisone—chronic obstructive pulmonary disease	0.000269	0.0007	CcSEcCtD
Pyridostigmine—ACHE—Metabolism of proteins—MUC1—chronic obstructive pulmonary disease	0.000262	0.00599	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism of proteins—MUC1—chronic obstructive pulmonary disease	0.000234	0.00535	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000229	0.00522	CbGpPWpGaD
Pyridostigmine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000224	0.00511	CbGpPWpGaD
Pyridostigmine—CYP3A4—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000221	0.00504	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism—APIP—chronic obstructive pulmonary disease	0.00021	0.00479	CbGpPWpGaD
Pyridostigmine—CYP3A4—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000201	0.00459	CbGpPWpGaD
Pyridostigmine—ACHE—ATF-2 transcription factor network—IL6—chronic obstructive pulmonary disease	0.000199	0.00454	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—APIP—chronic obstructive pulmonary disease	0.000187	0.00428	CbGpPWpGaD
Pyridostigmine—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000181	0.00414	CbGpPWpGaD
Pyridostigmine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000163	0.00371	CbGpPWpGaD
Pyridostigmine—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.00016	0.00366	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	0.00015	0.00342	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000139	0.00318	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	0.000138	0.00315	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism—GC—chronic obstructive pulmonary disease	0.000135	0.00309	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	0.000134	0.00305	CbGpPWpGaD
Pyridostigmine—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.000132	0.00301	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.000126	0.00287	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000124	0.00283	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	0.000123	0.00281	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism of proteins—ACE—chronic obstructive pulmonary disease	0.000121	0.00276	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—GC—chronic obstructive pulmonary disease	0.000121	0.00276	CbGpPWpGaD
Pyridostigmine—CYP3A4—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.000116	0.00265	CbGpPWpGaD
Pyridostigmine—CYP3A4—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.000115	0.00262	CbGpPWpGaD
Pyridostigmine—ACHE—Integrated Pancreatic Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	0.000112	0.00257	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.000112	0.00256	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism of proteins—PLAUR—chronic obstructive pulmonary disease	0.000109	0.00248	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism of proteins—ACE—chronic obstructive pulmonary disease	0.000108	0.00246	CbGpPWpGaD
Pyridostigmine—ACHE—Integrated Pancreatic Cancer Pathway—TGFB1—chronic obstructive pulmonary disease	0.000103	0.00236	CbGpPWpGaD
Pyridostigmine—ACHE—Integrated Pancreatic Cancer Pathway—EGFR—chronic obstructive pulmonary disease	0.000101	0.00231	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	0.0001	0.00229	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism of proteins—PLAUR—chronic obstructive pulmonary disease	9.7e-05	0.00221	CbGpPWpGaD
Pyridostigmine—ACHE—Integrated Pancreatic Cancer Pathway—TNF—chronic obstructive pulmonary disease	9.63e-05	0.0022	CbGpPWpGaD
Pyridostigmine—CYP3A4—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	9.63e-05	0.0022	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	9.5e-05	0.00217	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	8.94e-05	0.00204	CbGpPWpGaD
Pyridostigmine—ACHE—Integrated Pancreatic Cancer Pathway—TP53—chronic obstructive pulmonary disease	8.49e-05	0.00194	CbGpPWpGaD
Pyridostigmine—CYP3A4—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	8.03e-05	0.00183	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	7.92e-05	0.00181	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism of proteins—MMP1—chronic obstructive pulmonary disease	7.77e-05	0.00177	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism of proteins—LEP—chronic obstructive pulmonary disease	7.52e-05	0.00172	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism—GSTT1—chronic obstructive pulmonary disease	7.39e-05	0.00169	CbGpPWpGaD
Pyridostigmine—CYP3A4—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	7.38e-05	0.00169	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism—GCLC—chronic obstructive pulmonary disease	7.31e-05	0.00167	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	7.28e-05	0.00166	CbGpPWpGaD
Pyridostigmine—CYP3A4—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	7e-05	0.0016	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism of proteins—MMP1—chronic obstructive pulmonary disease	6.93e-05	0.00158	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	6.9e-05	0.00158	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	6.81e-05	0.00156	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism of proteins—LEP—chronic obstructive pulmonary disease	6.7e-05	0.00153	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism—CTGF—chronic obstructive pulmonary disease	6.67e-05	0.00152	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—GSTT1—chronic obstructive pulmonary disease	6.59e-05	0.00151	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—GCLC—chronic obstructive pulmonary disease	6.52e-05	0.00149	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism—CYP1A2—chronic obstructive pulmonary disease	6.14e-05	0.0014	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	6.08e-05	0.00139	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—CTGF—chronic obstructive pulmonary disease	5.95e-05	0.00136	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—APIP—chronic obstructive pulmonary disease	5.63e-05	0.00129	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—CYP1A2—chronic obstructive pulmonary disease	5.48e-05	0.00125	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism—GSTP1—chronic obstructive pulmonary disease	5.12e-05	0.00117	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism—HMOX1—chronic obstructive pulmonary disease	5.05e-05	0.00115	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism of proteins—CXCL8—chronic obstructive pulmonary disease	4.99e-05	0.00114	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism—GSTM1—chronic obstructive pulmonary disease	4.71e-05	0.00107	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—GSTP1—chronic obstructive pulmonary disease	4.57e-05	0.00104	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—HMOX1—chronic obstructive pulmonary disease	4.51e-05	0.00103	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism—CYP1A1—chronic obstructive pulmonary disease	4.46e-05	0.00102	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism of proteins—CXCL8—chronic obstructive pulmonary disease	4.46e-05	0.00102	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—GSTM1—chronic obstructive pulmonary disease	4.2e-05	0.000959	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—CYP1A1—chronic obstructive pulmonary disease	3.98e-05	0.000909	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	3.73e-05	0.000852	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—GC—chronic obstructive pulmonary disease	3.63e-05	0.000828	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	3.37e-05	0.00077	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism—ALB—chronic obstructive pulmonary disease	3.03e-05	0.000693	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism—NOS3—chronic obstructive pulmonary disease	2.9e-05	0.000663	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—ALB—chronic obstructive pulmonary disease	2.71e-05	0.000618	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—NOS3—chronic obstructive pulmonary disease	2.59e-05	0.000591	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.98e-05	0.000453	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	1.96e-05	0.000447	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	1.79e-05	0.000408	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.65e-05	0.000376	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.37e-05	0.000314	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.35e-05	0.000309	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.26e-05	0.000288	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.2e-05	0.000273	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	8.14e-06	0.000186	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	7.78e-06	0.000178	CbGpPWpGaD
